Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taizhou Orient Special Chemicals Co., Ltd. is a Chinese pharmaceutical manufacturing company established in 1999 and based in the Linhai industrial zone of Taizhou, Zhejiang Province. The company specializes in the development, production, and global supply of active pharmaceutical ingredients (APIs) and fine chemical intermediates. Its broad product portfolio focuses on therapeutic areas such as antivirals (ganciclovir, ribavirin), cardiovascular health (candesartan, amlodipine), and metabolic disorders (glimepiride). Operating from large-scale, GMP-certified facilities, the company is a significant supplier to both domestic and international pharmaceutical firms. Taizhou Orient Special Chemicals is recognized for its robust capabilities in complex organic synthesis and its adherence to international quality standards including US FDA and ISO certifications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taizhou Orient Special Chemicals.